BETA Technologies has completed five days of electric-aircraft operations in Utah to assess time-sensitive medical-cargo transport, using its all-electric ALIA CTOL with Alpine Air Express under the US Department of Transportation and Federal Aviation Administration’s eVTOL Integration Pilot Program. Flights linked Salt Lake City, Provo and Logan, focusing on radiopharmaceuticals used in diagnosing and treating diseases including cancer.
The operation was conducted with the Utah Department of Transportation and aerospace organisation 47G. Radiopharmaceuticals contain short-lived radioactive isotopes, creating a need for rapid and dependable delivery. Alpine Air already transports such medicines over longer distances with conventional aircraft; the trial is evaluating whether electric aircraft can complement those services and reach additional communities.
Data collection covered flight times, dispatch reliability, turnaround and charging times, weather, aircraft performance and operating costs. The results are intended to identify regional routes and conditions where electric aircraft could offer practical or economic benefits. The available information does not indicate the number of flights or payload volumes, and does not establish that the operation was revenue service or a permanent courier route.
The Utah activity follows a January 2025 partnership between BETA and 47G to develop electric aircraft and charging infrastructure in the state. BETA has also conducted eIPP missions in Virginia, Maryland, Louisiana, Texas and North Carolina.